Gentian Diagnostics ASA (GENT.OL)
NOK 39.0
(0.0%)
NOK 39.0
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -10.64 Million NOK | 56.85% |
| 2022 | -24 Million NOK | 3.2% |
| 2021 | -24.79 Million NOK | -44.88% |
| 2020 | -17.11 Million NOK | 57.06% |
| 2019 | -39.85 Million NOK | -101.31% |
| 2018 | -19.79 Million NOK | -30.51% |
| 2017 | -15.16 Million NOK | -69.93% |
| 2016 | -8.92 Million NOK | -177.05% |
| 2015 | -3.22 Million NOK | -10.78% |
| 2014 | -2.9 Million NOK | -432.79% |
| 2013 | 873.98 Thousand NOK | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 4.73 Million NOK | 13.8% |
| 2024 Q3 | 3.41 Million NOK | -27.87% |
| 2024 Q1 | 4.15 Million NOK | 142.47% |
| 2023 Q4 | -9.79 Million NOK | -1099.88% |
| 2023 FY | -10.35 Million NOK | 56.85% |
| 2023 Q1 | -955 Thousand NOK | 80.82% |
| 2023 Q3 | -816 Thousand NOK | -189.87% |
| 2023 Q2 | 908 Thousand NOK | 195.08% |
| 2022 Q3 | -10.01 Million NOK | -107.2% |
| 2022 Q1 | -7 Million NOK | 26.86% |
| 2022 FY | -24 Million NOK | 3.2% |
| 2022 Q4 | -4.98 Million NOK | 50.29% |
| 2022 Q2 | -4.83 Million NOK | 30.97% |
| 2021 Q3 | -6.78 Million NOK | -93.0% |
| 2021 FY | -24.79 Million NOK | -44.88% |
| 2021 Q2 | -3.51 Million NOK | 28.61% |
| 2021 Q1 | -4.92 Million NOK | -39.16% |
| 2021 Q4 | -9.57 Million NOK | -41.2% |
| 2020 Q2 | -1.41 Million NOK | 74.42% |
| 2020 Q1 | -5.53 Million NOK | 21.57% |
| 2020 FY | -17.11 Million NOK | 57.06% |
| 2020 Q4 | -3.53 Million NOK | 49.33% |
| 2020 Q3 | -6.98 Million NOK | -393.01% |
| 2019 FY | -39.85 Million NOK | -101.31% |
| 2019 Q4 | -7.05 Million NOK | -36.21% |
| 2019 Q3 | -5.18 Million NOK | 74.53% |
| 2019 Q1 | -7.27 Million NOK | 44.14% |
| 2019 Q2 | -20.34 Million NOK | -179.55% |
| 2018 Q4 | -13.02 Million NOK | -2104.46% |
| 2018 FY | -19.79 Million NOK | -30.51% |
| 2018 Q1 | -3.88 Million NOK | 26.49% |
| 2018 Q2 | -2.29 Million NOK | 40.75% |
| 2018 Q3 | -591 Thousand NOK | 74.29% |
| 2017 Q4 | -5.27 Million NOK | -6.09% |
| 2017 Q2 | 412 Thousand NOK | 107.73% |
| 2017 Q1 | -5.32 Million NOK | -94.14% |
| 2017 FY | -15.16 Million NOK | -69.93% |
| 2017 Q3 | -4.97 Million NOK | -1307.52% |
| 2016 Q4 | -2.74 Million NOK | 42.11% |
| 2016 Q2 | -356 Thousand NOK | 57.87% |
| 2016 Q1 | -845 Thousand NOK | 34.86% |
| 2016 FY | -8.92 Million NOK | -177.05% |
| 2016 Q3 | -4.74 Million NOK | -1232.02% |
| 2015 FY | -3.22 Million NOK | -10.78% |
| 2015 Q3 | -1.54 Million NOK | 0.0% |
| 2015 Q4 | -1.29 Million NOK | 15.99% |
| 2014 FY | -2.9 Million NOK | -432.79% |
| 2013 FY | 873.98 Thousand NOK | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Lifecare AS | -35.25 Million NOK | 69.8% |
| Medistim ASA | 103.82 Million NOK | 110.256% |